2013-2014 Graduate Catalog Downloadable PDF (10.71MB)

Texas A&MHealth Science Center 261612. Experimental Techniques in Molecular, Cell, and Systems Biology II. (2-4). Credit 4. Thiscourse is designed as a hands-on laboratory course to introduce the beginning graduate student to avariety of quantitative, analytical, cellular, histological, as well as ex vivo and in vivo techniques utilizedin biomedical research. Information is relayed through lectures, demonstrations, and hands-on experiencewith the techniques discussed. The objective of this course is to help the student gain some laboratoryexperience and, at the same time, become familiar with basic protocols for biomedical techniquesutilized in biological research. Prerequisite: Graduate classification and approval of course coordinator.613. Human Organ Systems I. Credit 5. This course is the first course of a two-course series designedas an advanced organ systems overview for students interested in a graduate level multidisciplinarystudy of human organ systems. The overall goal is to teach the student to understand how higher levelproperties of human biology arise from the complex interactions between the numerous, interactivecomponents of the system. The primary objective is to develop in graduate students the knowledge,appreciation, and integrated understanding of human biology, from a systems perspective. Prerequisite:MSCI 601 is preferred.614. Human Organ Systems II. Credit 5. This course is the second course of a two-course series designedas an advanced organ systems overview for students interested in a graduate level multidisciplinarystudy of human organ systems. The overall goal is to teach the student to understand how higher levelproperties of human biology arise from the complex interactions between the numerous, interactivecomponents of the system. The primary objective is to develop in graduate students the knowledge,appreciation, and integrated understanding of human biology, from a systems perspective. Prerequisite:MSCI 601 is preferred.615. Pathobiology and Therapeutics. (4-0). Credit 4. This course is designed to help students developthe ability to learn by themselves, with the oversight of a group of faculty mentors. Each student willchoose a disease model system from a chosen list of diseases/model systems that affect multiple systemsof the body. Students will collect and present information on how their chosen disease or integrativemodel system affects various organ systems. Students will put together an integrative proposal to presentto the class, followed by a final written proposal. Prerequisite: SBTM 613 and SBTM 614 or equivalent.624. Computational Systems Biology: Biostatistics. (2-0). Credit 2. Introduction to methods used toacquire, extract, organize, analyze, store and interpret the major types of data of interest in systems biology.Prerequisite: Approval of course director.625. Computational Systems Biology: Bioinformatics & Image Analysis. (2-0). Credit 2. Introductionto the methods used to acquire, extract, organize, analyze, store and interpret the major types ofinterest in systems biology. Prerequisite: Approval of course director.681. Seminar. Credit 1. Focus will be on critical scientific thinking. Emphasis placed on oral communications,scientific writing and grant preparation. Prerequisite: Graduate student in medicine. Approval ofinstructor.685. Directed Studies. Credit 1 to 6 each semester. Limited investigation in fields other than those chosenfor thesis or dissertation. Prerequisite: Approval of instructor.689. Special Topics In.... Credit 1 to 4. Selected topics in an identified area of System Biology and TranslationalMedicine. May be repeated for credit when topics vary. Prerequisite: Approval of the instructor.School of Graduate Studies(SGSI)600. Development & Commercialization of a Human Therapeutic. Credit 2. This course will cover thefundamentals of the commercialization of human therapeutics from research and discovery throughclinical development. In the course, students will gain an understanding of the process of the developmentand commercialization of a human therapeutic from early discovery through regulatory andproduct development to early clinical trials. Additionally, practical exercises in the business of buildingand sustaining a biotechnology company will be explored.